IMPACT OF SARCOPENIA ON SURVIVAL OF PATIENTS AFFECTED BY ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB

被引:0
|
作者
Reggidori, N. [1 ]
Lani, L. [1 ]
Renzulli, M. [2 ]
Gramenzi, A. [1 ]
Iannone, G. [1 ]
Granito, A. [1 ]
Piscaglia, F. [1 ]
Golfieri, R. [2 ]
Trevisani, F. [1 ]
Biselli, M. [1 ]
机构
[1] Dept Med & Surg Sci, Bologna, Italy
[2] Dept Specialist Diagnost & Sperimental Med, Bologna, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
T.08.10
引用
收藏
页码:S151 / S151
页数:1
相关论文
共 50 条
  • [21] Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
    Pinter, M.
    Sieghart, W.
    Hucke, F.
    Graziadei, I.
    Vogel, W.
    Maieron, A.
    Koenigsberg, R.
    Weissmann, A.
    Kornek, G.
    Matejka, J.
    Stauber, R.
    Buder, R.
    Gruenberger, B.
    Schoeniger-Hekele, M.
    Mueller, C.
    Peck-Radosavljevic, M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 949 - 959
  • [23] Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression
    Apostolidis, Leonidas
    Pfeiffenberger, Jan
    Gotthardt, Daniel
    Radeleff, Boris
    Mehrabi, Arianeb
    Schemmer, Peter
    Jaeger, Dirk
    Schirmacher, Peter
    Stremmel, Wolfgang
    Schulze-Bergkamen, Henning
    Springfeld, Christoph
    Weiss, Karl Heinz
    [J]. GASTROINTESTINAL TUMORS, 2018, 5 (1-2) : 38 - 46
  • [24] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E114 - E120
  • [25] Duration of Stable Disease Is Associated with Overall Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Arizumi, Tadaaki
    Ueshirna, Kazuomi
    Chishina, Hirokazu
    Kono, Masashi
    Takita, Mashiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Masatoshi
    [J]. DIGESTIVE DISEASES, 2014, 32 (06) : 705 - 710
  • [26] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E114 - E120
  • [27] Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: An Analysis of SEER-Medicare Database
    Parikh, Neehar D.
    Marshall, Vincent D.
    Nathan, Hari
    Balkrishnan, Rajesh
    Shahinian, Vahakn
    [J]. HEPATOLOGY, 2015, 62 : 409A - 410A
  • [28] Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Toyama, Tadashi
    Arai, Kuniaki
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    [J]. HEPATOLOGY RESEARCH, 2016, 46 (07) : 650 - 656
  • [29] Predictor factor of survival in advanced hepatocellular carcinoma treated with sorafenib ∼a multicenter study∼
    Ogawa, Chikara
    Morita, Masahiro
    Omura, Akina
    Shibatoge, Mitsushige
    Tsutsui, Akemi
    Senoh, Tomonori
    Nagano, Takuya
    Takaguchi, Kouichi
    Tani, Joji
    Morishita, Asahiro
    Yoneyama, Hirohito
    Masaki, Tsutomu
    Moriya, Akio
    Ando, Masaharu
    Deguchi, Akihiro
    Kudo, Masatoshi
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [30] Impact of Pretreatment Serum Cholinesterase Level in Unresectable Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib
    Takeda, Haruhiko
    Nishikawa, Hiroki
    Sakamoto, Azusa
    Nasu, Akihiro
    Kita, Ryuichi
    Kimura, Toru
    Osaki, Yukio
    [J]. HEPATOLOGY, 2012, 56 : 469A - 470A